Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Oncology > 2026 Vol. 1 > No. 1 > 100006
Next Article Previous Article
COMMENTARY   Open Access     Cite

How does the probiotic empower immunotherapy for colorectal cancer?

  • 1.

    Department of Environmental Hygiene, School of Public Health, Harbin Medical University, Harbin 150081, China

  • 2.

    Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China

More Information
  • Corresponding author: gaoyizhou@yeah.net
  • Received Date:  January 23, 2026
    Accepted Date:  April 06, 2026
    Published Online:  April 17, 2026
The Innovation Oncology  1(1),  https://doi.org/10.59717/j.xinn-oncol.2026.100006  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Xie M., Yuan K., Zhang Y., et al. (2025). Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression. Cancer Cell 43:1885–1901.e10. DOI:10.1016/j.ccell.2025.07.012

    View in Article Google Scholar

    [2] Stoeva M.K., Garcia-So J., Justice N., et al. (2021). Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes 13:1−28. DOI:10.1080/19490976.2021.1907272

    View in Article CrossRef Google Scholar

    [3] Yu L., Guo Q., Gu X., et al. (2025). Impact of gut microbiome on radiotherapy and immunotherapy efficacy in microsatellite-stable colorectal cancer: Role of propionic acid and B. fragili. Br. J. Cancer 133:956−969. DOI:10.1038/s41416-025-03105-2

    View in Article CrossRef Google Scholar

    [4] Qiu Y.-S., Ye C., Li Q., et al. (2025). Improved gut microbiota by selenium-enriched Bifidobacterium longum DD98 alleviates chemotherapy-induced intestinal mucositis via inhibiting the STING pathway. npj Sci. Food 9:107. DOI:10.1038/s41538-025-00473-0

    View in Article CrossRef Google Scholar

    [5] Redenti A., Im J., Redenti B., et al. (2024). Probiotic neoantigen delivery vectors for precision cancer immunotherapy. Nature 635:453−461. DOI:10.1038/s41586-024-08033-4

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Liu W., Wang J. and Gao Y.-Z. (2026). How does the probiotic empower immunotherapy for colorectal cancer? The Innovation Oncology 1:100006. https://doi.org/10.59717/j.xinn-oncol.2026.100006
    Liu W., Wang J. and Gao Y.-Z. (2026). How does the probiotic empower immunotherapy for colorectal cancer? The Innovation Oncology 1:100006. https://doi.org/10.59717/j.xinn-oncol.2026.100006

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(973) PDF downloads(230)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.